10.1021/acsomega.9b04369.s001 Ali Altharawi Ali Altharawi Khondaker Miraz Rahman Khondaker Miraz Rahman Ka Lung Andrew Chan Ka Lung Andrew Chan Identifying the Responses from the Estrogen Receptor-Expressed MCF7 Cells Treated in Anticancer Drugs of Different Modes of Action Using Live-Cell FTIR Spectroscopy American Chemical Society 2020 well-characterized anticancer classes breast cancer cell line MDA-MB -231 cell cell lines Living MCF 7 cells PCA SERM doxorubicin-treated MCF 7 cells doxorubicin-treated MDA-MB -231 Estrogen Receptor-Expressed MCF 7 Cells Treated MCF 7 cells DNA intercalation effect anticancer drugs MCF 7 cells show estrogen-expressing MCF 7 cells live-cell FTIR analysis PC 2 score plots MCF 7 cell line Live-Cell FTIR Spectroscopy IC MDA-MB -231 cells estrogen receptor modulators 2020-05-23 00:13:21 Journal contribution https://acs.figshare.com/articles/journal_contribution/Identifying_the_Responses_from_the_Estrogen_Receptor-Expressed_MCF7_Cells_Treated_in_Anticancer_Drugs_of_Different_Modes_of_Action_Using_Live-Cell_FTIR_Spectroscopy/12361079 Recently, we have shown that changes in Fourier transform infrared (FTIR) spectra of living MDA-MB-231 cells (a triple negative cell line) upon exposure to anticancer drugs reflect the changes in the cellular compositions which are correlated to the modes of action of drugs. In the present study, MCF7 cells (an estrogen receptor expressing breast cancer cell line) were exposed to three anticancer drugs belonging to two well-characterized anticancer classes: selective estrogen receptor modulators (SERMs) and DNA-intercalating agent. First, we evaluated if the changes in the spectrum of cells are according to the modes of action of drugs and the characteristics of the MCF7 cell line in the same way as the MDA-MB-231 cell. Living MCF7 cells were treated in the three drugs at half maximal inhibitory concentration (IC50), and the difference spectra were analyzed using principal component analysis (PCA). The results demonstrated clear separation between tamoxifen/toremifene (SERM)-treated cells from the doxorubicin (DNA-intercalator)-treated and untreated cells (control). Tamoxifen and toremifene induced similar spectral changes in the cellular compositions of MCF7 cells and lead to the clustering of these two drugs in the same quadrant of the principal component 1 (PC1) versus PC2 score plots. The separation is mostly attributed to their similar modes of actions. However, doxorubicin-treated MCF7 cells highlighted spectral changes that mainly occur in bands at 1085 and 1200–1240 cm<sup>–1</sup>, which could be associated with the DNA-intercalation effects of the drug. Second, the pairwise PCA at various individual time points was employed to investigate whether the spectral changes of MCF7 and MDA-MB-231 cells in response to the IC50 of tamoxifen/toremifene and doxorubicin are dependent on the characteristics of the cell lines. The estrogen-expressing MCF7 cells demonstrated significant differences in response to the SERMs in comparison to the triple negative MDA-MB-231 cells, suggesting that different modes of action have taken place in the two tested cell lines. In contrast, the doxorubicin-treated MDA-MB-231 and MCF7 cells show similar changes in 1150–950 cm<sup>–1</sup>, which indicates that the DNA intercalation effect of doxorubicin is found in both cell lines. The results have demonstrated that live-cell FTIR analysis is sensitive to the different modes of action from the same drugs on cells with different characteristics.